Why the study?
Does the Trifecta bioprosthetic aortic valve improve postoperative haemodynamic performance compared to the Magna Ease bioprosthesis in patients undergoing aortic valve replacement?
Population
791 patients who underwent aortic valve replacement at eight European institutions between January 2011 and…
Comparison
Trifecta bioprosthetic aortic valve (n=322) vs Magna Ease aortic valve bioprosthesis (n=469)
Design
Cohort
Follow-up
minimum 6 months, maximum 12 months
Authors
Loading...
Trifecta may favor better early hemodynamics in AVR; leaves open durability and clinical outcomes.
Does the Trifecta bioprosthetic aortic valve improve postoperative haemodynamic performance compared to the Magna Ease bioprosthesis in patients undergoing aortic valve replacement?
The Trifecta bioprosthesis provides superior early haemodynamic performance and lower rates of severe prosthesis-patient mismatch compared to the Magna Ease valve in patients undergoing aortic valve replacement.
Colli et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: